The following were some of the top movers in after-hours trading on Friday.
Aclarion Inc. (ACON), a healthcare technology company, has reconvened its Special Meeting of Stockholders on March 5, 2025. The meeting was originally scheduled for February 28, 2025. The company's lead investigational product is NOCISCAN, a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. A pivotal trial designed to validate Nociscan's ability to improve surgical outcomes for chronic low back pain patients, dubbed CLARITY, is underway.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com